Loblaw, CA5394811015

Loblaw stock: Q3 sales rise as adjusted EPS gains 8.8%

Published on 11/19/2026 at 13:26 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Loblaw stock is in focus after a quarter of higher retail sales and operating income. Management maintained its full-year outlook and plans further share repurchases.

Quarterly growth and capital allocation

  • Loblaw increased retail sales and operating income in the third quarter, led by drug retail and e-commerce.
  • Management maintained its full-year outlook for high-single-digit adjusted earnings-per-share growth and approximately 2.4 billion Canadian dollars in capital spending.
  • The company declared a quarterly dividend payable on December 30 to shareholders of record on December 15.
Loblaw, CA5394811015, Illustration mit AI erstellt.

Loblaw Companies Limited reported its third-quarter results on Thursday, November 19, according to a GlobeNewswire release. Retail sales increased 3.6 percent to 19,857 million Canadian dollars in the 16 weeks ended October 10, while adjusted diluted net earnings per common share rose 8.8 percent to 0.74 Canadian dollars.

Loblaw stock traded at 44.90 euros on Lang & Schwarz at 13:19 CET on Thursday, November 19.

Retail operations remain the earnings engine

Food Retail sales rose 2.8 percent to 14,048 million Canadian dollars, with same-store sales up 0.6 percent. Drug Retail sales increased 5.7 percent to 5,809 million Canadian dollars, while same-store sales advanced 4.8 percent. Pharmacy and healthcare services grew 7.6 percent on a same-store basis, supported by specialty and chronic prescriptions.

E-commerce sales grew 16.9 percent during the quarter. Loblaw opened 18 food and drug stores and closed one drug store, expanding retail square footage by 1.8 percent from a year earlier. The company said more than four million questions had been asked through its PC Chat healthcare service since launch.

Operating income increased 9.7 percent to 1,408 million Canadian dollars. Adjusted EBITDA rose 6.9 percent to 2,250 million Canadian dollars, lifting the adjusted EBITDA margin to 11.3 percent from 11.0 percent. Retail free cash flow was 324 million Canadian dollars, down from 347 million Canadian dollars in the comparable period, while gross capital investments reached 897 million Canadian dollars.

Reported earnings include portfolio changes

Net earnings available to common shareholders climbed to 1,193 million Canadian dollars from 794 million Canadian dollars. The comparison benefited from a 401 million Canadian dollar after-tax gain connected with the sale of PC Financial, which was presented as discontinued operations. Adjusted net earnings from continuing operations rose to 857 million Canadian dollars from 770 million Canadian dollars.

The company also disclosed that it sold its interest in QHR Technologies to LGI Healthcare Solutions on November 18 for approximately 236 million Canadian dollars. Loblaw said the gain on that sale was still being finalized and would be recognized in the fourth quarter.

Outlook and shareholder returns

Loblaw maintained its 2026 outlook. The company expects its Retail business to grow earnings faster than sales, with adjusted net earnings per common share growth in the high single digits. It also plans approximately 2.4 billion Canadian dollars in gross capital expenditures for stores and distribution centres.

Share repurchases remain a central part of the capital-allocation plan. Loblaw repurchased and cancelled 8.3 million common shares for 524 million Canadian dollars during the quarter, bringing year-to-date repurchases to 27.3 million shares for 1,724 million Canadian dollars. The board also declared a quarterly dividend of 0.155183 Canadian dollars per common share, payable December 30 to shareholders of record on December 15.

For investors, the quarter points to continued momentum in pharmacy, healthcare services and digital commerce, while food retail growth remained more modest. The sale of PC Financial and the QHR transaction further reshape the portfolio and make continuing retail operations the main lens for assessing Loblaw's earnings trajectory.

Loblaw Companies Limited

  • ISIN: CA5394811015
  • Exchange ticker: L on the Toronto Stock Exchange
  • Lang & Schwarz price: 44.90 euros at 13:19 CET on Thursday, November 19, 2026
  • Third-quarter retail sales: 19,857 million Canadian dollars
  • Adjusted diluted earnings per common share: 0.74 Canadian dollars

The broader Canadian market context is available through the S&P/TSX Composite.

More news and analyses on Loblaw stock

Disclaimer...
en | CA5394811015 | LOBLAW | boerse | 70535886 | bgmi